Falk Kerac N, Satola Sarah W, Chassagne François, Northington Gina M, Quave Cassandra L
From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Gynecology and Obstetrics.
Department of Medicine, Division of Infectious Diseases.
Female Pelvic Med Reconstr Surg. 2022 Apr 1;28(4):e127-e132. doi: 10.1097/SPV.0000000000001124. Epub 2021 Nov 10.
The aims of this study were to assess the in vitro biofilm-producing capabilities of uropathogens grown from a postmenopausal urogynecologic population with isolated and recurrent urinary tract infection (UTI) and to determine whether the biofilm-producing bacterial phenotype was associated with recurrent infection.
This was an institutional review board-approved cross-sectional analysis within a large academic referral center. Uropathogens were cultured from postmenopausal women with either isolated or recurrent acute UTI and then screened for in vitro biofilm formation using crystal violet microtiter assays. Demographic and clinical variables, including pelvic floor symptoms and surgical history were collected and analyzed. A multivariate model was developed to determine whether recurrent UTI was independently associated with biofilm production.
Eighty-nine women were included: 67.4% White, 25.8% Black, 3.4% Asian, and 1.1% Hispanic with a mean age of 72 ± 10.5 years. Ninety-five uropathogen strains were isolated. Most uropathogens produced biofilm (n = 53, 55.8%). Uropathogens from women with recurrent UTI were significantly more likely to produce biofilm (70%) than uropathogens collected from women with isolated UTI (38.6%, P = 0.0033). Adjusting for age, prior pelvic reconstructive surgery, and body mass index, recurrent UTI bacteria were more likely to produce biofilm, compared with isolated UTI (odds ratio, 5.37; 95% confidence interval, 2.0-14.4; P = 0.001).
In this cohort of postmenopausal urogynecology patients, in vitro biofilm formation was more frequently observed in uropathogens isolated from women with recurrent UTI compared with women with isolated UTI. Further study is needed to assess the role of biofilms in recurrent UTIs in postmenopausal women.
本研究旨在评估从患有孤立性和复发性尿路感染(UTI)的绝经后泌尿妇科人群中培养出的尿路病原体的体外生物膜形成能力,并确定产生生物膜的细菌表型是否与复发性感染相关。
这是一项在大型学术转诊中心进行的经机构审查委员会批准的横断面分析。从患有孤立性或复发性急性UTI的绝经后女性中培养尿路病原体,然后使用结晶紫微量滴定法筛选体外生物膜形成。收集并分析人口统计学和临床变量,包括盆底症状和手术史。建立多变量模型以确定复发性UTI是否与生物膜产生独立相关。
纳入89名女性:67.4%为白人,25.8%为黑人,3.4%为亚洲人,1.1%为西班牙裔,平均年龄为72±10.5岁。分离出95株尿路病原体菌株。大多数尿路病原体产生生物膜(n = 53,55.8%)。与从患有孤立性UTI的女性中分离出的尿路病原体(38.6%)相比,从患有复发性UTI的女性中分离出的尿路病原体产生生物膜的可能性显著更高(70%,P = 0.0033)。在调整年龄、既往盆底重建手术和体重指数后,与孤立性UTI相比,复发性UTI细菌产生生物膜的可能性更大(优势比,5.37;95%置信区间,2.0 - 14.4;P = 0.001)。
在这组绝经后泌尿妇科患者中,与患有孤立性UTI的女性相比,从患有复发性UTI的女性中分离出的尿路病原体中更频繁地观察到体外生物膜形成。需要进一步研究以评估生物膜在绝经后女性复发性UTIs中的作用。